The goal of the Cancer Immunotherapy and Immunomonitoring (CITIM) conference is to advance medical and biomedical immunological sciences and clinical practice. CITIM provides an environment of stimulating scientific discussions, exchange of ideas that considers novel clinical diagnostic and therapeutic approaches.


Conference Sessions:

Session I: Inflammation and Immunity in the Tumor Microenvironment
Session II: Regulatory and Effector Mechanisms in the Tumor Environment
Session III: Tumor Microenvironment and Cancer Immunotherapy
Session IV: Preclinical Models of Cancer Immunotherapy: Prognostic and Therapeutic Significance
Session V: Cancer Immunotherapy: Lessons and Perspectives
Session VI: Cancer Immunotherapy: Regulatory Cells and Cytokines
Session VII: Cancer Immunotherapy: New Approaches
Session VIII: Cancer Biomarkers and Immunomonitoring in Cancer Clinical Trials


By providing abstract, travel and clinical scientist awards, the CITIM conference supports creativity and uniqueness in order to inspire a strong basic research portfolio and achieve the rapid translation of insights gleaned from research laboratories to bedside worldwide. CITIM serves biomedical scientists and researchers, Primary Care physicians, medical residents and fellows, RN, medical technologists, postdoctoral fellows, medical and graduate students and everybody who is interested in recent developments in the fields of basic, clinical, laboratory and medical immunology.